Evolution of our Company Name

Our story begins when new building turnover did not necessarily mean a working building. Technological advances led to increased specialization. The traditional roles had splintered into many narrowly defined responsibilities, which resulted in project teams with no centralized or integrated quality control. So, we formed a company to take on lagging building performance and help [...]

By | 2018-01-23T11:48:37+00:00 January 23rd, 2018|Categories: Blog|0 Comments

Rise Up

On Wednesday, June 7th, the Holder-Hunt-Moody-Russell Joint Venture threw a Topping Out Celebration and Luncheon at the Mercedes-Benz stadium. All the firms working on the project were invited to celebrate the hard work everyone has put in to get the stadium completed. A group of us arrived at the stadium and were given hardhats, neon-green safety [...]

By | 2017-11-07T13:45:46+00:00 June 22nd, 2017|Categories: Blog|0 Comments

The Research of Our Clients

Our services are ancillary to some exciting, groundbreaking research. But we rarely get the opportunity to openly discuss—or even direct attention to—this research because our clients prefer to work in private, away from the spotlight. Occasionally, though, the research attracts national attention and CNN does a nice write-up and video feature on said research. At [...]

By | 2017-11-07T13:45:46+00:00 June 1st, 2017|Categories: Blog|0 Comments

WorkingBuildings Awarded Contracts With Two Agencies Under the Department of Health & Human Services

The Centers for Disease Control and Prevention (CDC) selected WorkingBuildings for a five-year, $25 million indefinite delivery / indefinite quantity (ID/IQ) contract for Facilities Planning and Real Estate Advisory Services for its nationwide facilities inventory and for its international facilities program, which includes both CDC-occupied facilities and facilities for host-nation governments. CDC is recognized around [...]

By | 2017-02-21T16:15:37+00:00 October 17th, 2016|Categories: Press Releases|Tags: , , , |0 Comments

WorkingBuildings Awarded Contracts With Two Prominent Southeast Health Systems

WorkingBuildings is proud to announce the award of contracts with two esteemed healthcare institutions in the southeast: Piedmont Healthcare and Mission Health. Piedmont Healthcare’s $603 million overhaul of their hospital’s main campus in Buckhead will add 114 general hospital beds and a new 16-story tower to the campus. The new Marcus Tower will be anchored [...]

By | 2017-11-07T13:45:47+00:00 October 12th, 2016|Categories: Press Releases|Tags: , , , |0 Comments

Michael Weiss’s article in ALN about Transitional Operations:

Four Objectives for Transitional Operations to a New Facility A consistent drawback of the traditional design/construction process of delivering complex facilities is the inevitable “mad rush” at the end to turn over the facility. Compressed schedules and shifting priorities often leave the occupants ill-prepared to fully operate a new facility or program and require them to [...]

By | 2017-11-07T13:45:47+00:00 September 28th, 2016|Categories: In The News|0 Comments

FDA Grants “Breakthrough Status” for Promising Cancer Treatment, 60 Minutes Reports

For two years, 60 Minutes has followed the clinical trials at Duke University where a modified version of the polio virus is being used to eliminate brain cancer tumors called Glioblastoma. The FDA had previously approved the trial in humans in 2011, and has recently granted the treatment "breakthrough status" which means that the clinical [...]

By | 2016-06-02T19:29:37+00:00 June 2nd, 2016|Categories: In The News|Tags: , , , , , |0 Comments

The Kendeda Fund Selects John McFarland as Donor’s Representative

ATLANTA, May 18, 2016 -- John McFarland, Vice President & Principal at The WorkingBuildings Group of Companies, was selected as the Donor's Representative for the Living Building Challenge Certified Facility through The Kendeda Fund, an Atlanta-based philanthropic organization. McFarland will provide guidance and input to The Kendeda Fund while working with Georgia Tech to design [...]

US National Cancer Institute stops making cell therapy in light of contamination risk

Cell therapy and radiotracer production has halted at two facilities operated by the US National Institutes of Health (NIH) after consultants raised concerns about quality and manufacturing standards. Read more on In-Pharma Technologist

By | 2016-06-02T19:28:57+00:00 April 21st, 2016|Categories: In The News|Tags: , , , , , , |0 Comments

WB Newsletter

Contact Info

1230 Peachtree St. NE, 300 Promenade, Atlanta, GA 30309

Phone: +1 678-990-8001

Fax: +1 678-990-5399